Enzyme-Linked Immunosorbent Assay (ELISA): A US Market Report
San Jose, CA (Vocus) June 9, 2010
Enzyme-Linked Immunosorbent Assay (ELISA) is one of the few assay formats that has managed to command widespread popularity, in terms of reproducibility, performance, and validation, particularly in a rapidly changing life sciences and drug discovery market. Adherence with stringent quality control and validation requirements has ensured minimal high-cost failures. The advent of proteomics led to a significant expansion in the availability of protein targets for assay development, thereby fostering the development of kits for large family of proteins as well as for proteins in unrelated, niche research segments.
The Research ELISA market faces challenges due to the commoditization of ELISA products. The advanced multiplex technology, with multiple-analyte quantification technique, continues to gain popularity over the single-analyte technique of ELISA, as stated by the new market research report on Enzyme-Linked Immunosorbent Assay (ELISA) market. Majority of the end-users are opting for multiplex proteomic arrays, as a result of which ELISA products have largely been restricted to laboratories seeking cost-effective technology options. On the other hand, the commoditization of ELISA products has enhanced price-related pressures for manufacturers, particularly from bulk purchase customers. However, favorable reputation of ELISA Kits as a trusted technology for research markets, continued use in secondary validation for select targets by multiplex customers, and developments in the field of biomarkers resulting in the availability of new targets is expected to ensure revenue generation in the Research ELISA market. The cost-effective ELISA products are preferred by laboratories and researchers that focus on less number of analytes and high sensitivity of assay. The market for Research ELISA Kits is expected to witness significant erosion, and is forecast to record revenues of US$55 million by 2012.
The ELISA market involves the participation of a wide range of players including life science reagent manufacturers, large multi-industry reagent manufacturers, and diversified reagent providers. Leading players profiled in the report include Abbott Diagnostics, Becton, Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories Inc., EMD Biosciences Inc., Life Technologies Corporation, Millipore Corporation, Ortho-Clinical Diagnostics Inc., Research & Diagnostics Systems Inc., and Thermo Fisher Scientific Inc.
The report titled “Enzyme-Linked Immunosorbent Assay (ELISA): A US Market Report” announced by Global Industry Analysts, Inc., provides a review of market trends, product introductions/innovations, and recent industry activity. The study analyzes market data and analytics in terms of annual revenues by the following segments - ELISA Kits and ELISA Development Sets and Antibody Pairs.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com/